Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McKesson Takes Over VA Contract From AmerisourceBergen May 10

Executive Summary

AmerisourceBergen will serve the Department of Veterans Affairs pharmaceutical prime vendor contract through May 9 at a fee of cost minus 5%
Advertisement

Related Content

Dropping Rx Lines Would Be Costly Distribution Negotiation Tactic, ABC Says
Dropping Rx Lines Would Be Costly Distribution Negotiation Tactic, ABC Says
AmerisourceBergen Expects Fee-For-Service Transition To Last Two Years
AmerisourceBergen Expects Fee-For-Service Transition To Last Two Years
Rite Aid Eyes Eckerd Customers During Transition; Profits Recovering
McKesson Bid Offers VA $1.2 Bil. In Savings, Court Says In ABC Challenge
VA Wholesaler Dispute: McKesson And ABC Head To Court In March
McKesson/VA Contract Is Cost-5%; “Irresponsible,” Amerisource Says
McKesson/VA Contract Is Cost-5%; “Irresponsible,” Amerisource Says
McKesson Takes VA Contract From Amerisource, Cites Technology As Reason
Advertisement
UsernamePublicRestriction

Register

PS043628

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel